WallStreetZenWallStreetZen

NASDAQ: HOTH
Hoth Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Hoth Therapeutics earnings were -$12.5M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest HOTH earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$2.7M, down 34.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, HOTH reported annual earnings of -$12.5M, with 52.3% growth.

HOTH earnings history

Current Revenue
$0.0
Current Earnings
-$12.5M
Current Profit Margin
0%

HOTH Return on Equity

Current Company
-139.8%
Current Industry
-31.4%
Current Market
28.9%
HOTH's Return on Equity (-139.8%)... subscribe to Premium to read more.
High Return on Equity Performance

HOTH Return on Assets

Current Company
-126.9%
Current Industry
-9.6%
HOTH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HOTH announces earnings.

HOTH Return on Capital Employed

Current Company
-202.73%
Current Industry
-3.7%
HOTH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HOTH vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HOTH-$12.47M-$12.47MN/A-$0.90
CMMB-$8.93M-$9.00MN/A-$1.44
KAPA-$5.29M-$5.45MN/A-$0.30
BCDA-$7.72M-$8.23MN/A-$1.23
GDTC-$2.78M-$3.11MN/A-$0.27
View Top Biotech Stocks

Hoth Therapeutics Earnings Reports & History FAQ

What were Hoth Therapeutics's earnings last quarter?

Hoth Therapeutics (NASDAQ: HOTH) reported Q4 2025 earnings per share (EPS) of -$0.16, up 42.86% year over year. Total HOTH earnings for the quarter were -$2.69 million. In the same quarter last year, Hoth Therapeutics's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Hoth Therapeutics stock.

Is Hoth Therapeutics profitable or losing money?

As of the last Hoth Therapeutics earnings report, Hoth Therapeutics is currently losing money. Hoth Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$12.47 million, a 52.28% increase year over year.

What was HOTH's earnings growth in the past year?

As of Hoth Therapeutics's earnings date in Q2 2026, Hoth Therapeutics's earnings has grown year over year. HOTH earnings in the past year totalled -$12.47 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.